Carol Lutz

Carol Lutz has extensive work experience in the field of business operations and management. Carol is currently working as the Business Operations Director at Taysha Gene Therapies since May 2021. Prior to this, Carol held the position of Project Manager at Novartis Gene Therapies from November 2018 to April 2021.

Before entering the gene therapy industry, Carol worked at Homeside Realty as "Living the Dream" from February 2017 to November 2018. Carol then joined GSK, where they held two roles - Technical Research & Development Business Operations Manager from February 2016 to December 2017, and Business Operations Manager for Global Contract Manufacturing from March 2015 to January 2016.

Carol's career started at Novartis Vaccines and Diagnostics in July 2010, where they served as Business Operations Manager for Global Contract Manufacturing and also held the role of Executive Assistant for Global Supply Chain until March 2015.

Their earlier experience includes working at IBM Corporation in multiple roles, such as Associate Director - Product Marketing from September 2008 to February 2009, Program Director | Business Operations Manager from June 2006 to September 2008, and Senior Events Manager | Program Manager from December 1997 to June 2006.

Throughout their career, Carol has demonstrated their expertise in business operations, project management, and contract manufacturing.

Carol Lutz has a Bachelor of Science in Business Administration with a focus on Personnel Management (Human Resources) and Public Administration from Truman State University. Additionally, they have also pursued studies in the Biotechnology Program at Wake Technical Community College, although no specific degree information is provided.